JP2022541646A5 - - Google Patents
Info
- Publication number
- JP2022541646A5 JP2022541646A5 JP2022505209A JP2022505209A JP2022541646A5 JP 2022541646 A5 JP2022541646 A5 JP 2022541646A5 JP 2022505209 A JP2022505209 A JP 2022505209A JP 2022505209 A JP2022505209 A JP 2022505209A JP 2022541646 A5 JP2022541646 A5 JP 2022541646A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- cdr3
- antibody
- cdr1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2019902642 | 2019-07-25 | ||
| AU2019902642A AU2019902642A0 (en) | 2019-07-25 | Methods and agents for treating acute neuroinflammatory injury | |
| PCT/US2020/043619 WO2021016601A1 (en) | 2019-07-25 | 2020-07-24 | Methods and agents for treating acute neuroinflammatory injury |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022541646A JP2022541646A (ja) | 2022-09-26 |
| JP2022541646A5 true JP2022541646A5 (cg-RX-API-DMAC7.html) | 2023-07-31 |
Family
ID=74192699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022505209A Pending JP2022541646A (ja) | 2019-07-25 | 2020-07-24 | 急性神経炎症傷害を処置するための方法および薬剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220249610A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4003518A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022541646A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220040478A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114450068A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020316519A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL290046A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021016601A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019144141A1 (en) * | 2018-01-22 | 2019-07-25 | UNIVERSITY OF VIRGINIA PATENT FOUNDATION d/b/a UNIVERSITY OF VIRGINIA LICENSING & VENTURE | System and method for automated detection of neurological deficits |
| CN116367858A (zh) * | 2020-09-10 | 2023-06-30 | 隐式生物科技有限公司 | 用于治疗心肌梗塞的治疗方法和试剂 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5820858A (en) | 1993-05-28 | 1998-10-13 | The Scripps Research Institute | Methods and compositions for inhibiting CD14 mediated cell activation |
| AU2001290315A1 (en) | 2000-11-22 | 2002-06-03 | Mochida Pharmaceutical Co., Ltd. | Anti-cd14 monoclonal antibody having effect of inhibiting cd14/tlr binding |
| WO2006063292A1 (en) | 2004-12-08 | 2006-06-15 | Icos Corporation | Recombinant method for making multimeric proteins |
| CA2609262A1 (en) * | 2005-06-03 | 2006-12-07 | Mochida Pharmaceutical Co., Ltd. | Anti-cd14 antibody fusion protein |
| PL2034830T3 (pl) * | 2006-05-25 | 2015-04-30 | Biogen Ma Inc | Przeciwciało anty-VLA-1 do leczenia udaru |
| WO2008088902A2 (en) * | 2007-01-17 | 2008-07-24 | Yale University | Attenuation of the adaptive immune response |
| WO2018165720A1 (en) * | 2017-03-17 | 2018-09-20 | Implicit Bioscience Pty Ltd | Agents for treating or preventing viral infections and uses therefor |
| IL309046B2 (en) * | 2017-04-21 | 2025-03-01 | Implicit Bioscience Ltd | CD14 antagonist antibodies for the treatment of neurodegenerative diseases |
-
2020
- 2020-07-24 CN CN202080067788.1A patent/CN114450068A/zh active Pending
- 2020-07-24 JP JP2022505209A patent/JP2022541646A/ja active Pending
- 2020-07-24 WO PCT/US2020/043619 patent/WO2021016601A1/en not_active Ceased
- 2020-07-24 US US17/629,763 patent/US20220249610A1/en active Pending
- 2020-07-24 EP EP20843606.3A patent/EP4003518A4/en active Pending
- 2020-07-24 KR KR1020227006319A patent/KR20220040478A/ko active Pending
- 2020-07-24 AU AU2020316519A patent/AU2020316519A1/en active Pending
-
2022
- 2022-01-23 IL IL290046A patent/IL290046A/en unknown